European regulatory framework for the clinical translation of bioprinted scaffolds and tissues


Published: 14 February 2020
Abstract views:
848


PDF:
437
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Licia Di Pietro Research Center E. Piaggio and Department of Information Engineering, University of Pisa, Pisa, Italy.
  • Alice Ravizza Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
  • Giovanni Vozzi Research Center E. Piaggio and Department of Information Engineering, University of Pisa, Pisa, Italy.
  • Andrés Diaz Lantada Universidad Politécnica de Madrid, Madrid, Spain, Spain.
  • Arti Ahluwalia Research Center E. Piaggio and Department of Information Engineering, University of Pisa, Pisa, Italy.
  • Carmelo De Maria Research Center E. Piaggio and Department of Information Engineering, University of Pisa, Pisa, Italy.

Tissue Engineering and Regenerative medicine, empowered by Biofabrication technologies, hold the premises to provide solutions to unmet clinical needs, such as organ donor shortage or genetic diseases. These huge advancements are determining a changing scenario, with a quite confusing understanding about the steps toward the clinical translation of new researches and products, giving as result an overestimation or an underestimation of the required in vitro and in vivo tests for their validation. The proper definition and classification of the research products can be considered an action toward the refinement of animal experiments. An appropriate classification is crucial because the complications due to the combination of biological and non-biological materials need the application of specific rules. This paper aims at helping the academic and industrial community to clarify the identification and classification of their research products.


Di Pietro, L., Ravizza, A., Vozzi, G., Diaz Lantada, A., Ahluwalia, A., & De Maria, C. (2020). European regulatory framework for the clinical translation of bioprinted scaffolds and tissues. Biomedical Science and Engineering, 1(1). https://doi.org/10.4081/bse.108

Downloads

Download data is not yet available.

Citations

Most read articles by the same author(s)